Jyoti Mayadev - Concepedia

Author

Jyoti Mayadev

University of California San Diego ORCID

Also Known As

Hubbard, Anne, J Mayadev, J. Mayadev, J.S. Mayadev, Jyoti Mayadev, Jyoti S Mayadev, Jyoti S. Mayadev, Jyoti S. Mayadev, Mayadev, Jyoti

235

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

University of California San Diego University of California, Davis University of California Davis Medical Center NRG Oncology UC Davis Comprehensive Cancer Center

About

Jyoti Mayadev is an author at University of California San Diego specializing in radiation oncology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	30	1.2K
2	Health Sciences	14	17	724
3	Public Health	9	9	395
4	Engineering	1	1	31
5	Cellular Therapies	1	1	41

Jyoti Mayadev

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline Junzo Chino, Christina M. Annunziata, Sushil Beriwal, Practical Radiation Oncology Cervical Cancer ManagementRadiation MedicineCervical CancerRadiation TherapyCervical Health	2020	281
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial Bradley J. Monk, Takafumi Toita, Xiaohua Wu, The Lancet Oncology Advanced Cervical CancerCervical Cancer ManagementCervical CancerCervical HealthMedicine	2023	182
Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Patients With Node-Positive Cervical Cancer Jyoti Mayadev, Danielle Enserro, Yvonne G. Lin, JAMA Oncology	2019	99
CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study Jyoti Mayadev, Ana T. Nunes, Mary Li, International Journal of Gynecological Cancer	2020	87
Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929) Diane M. Da Silva, Danielle Enserro, Jyoti Mayadev, Clinical Cancer Research	2020	66
A failure modes and effects analysis study for gynecologic high-dose-rate brachytherapy Jyoti Mayadev, Sonja Dieterich, R. Harse, Brachytherapy Radiation TherapyEffects Analysis StudyBrachytherapyGynecologyGynecologic High-dose-rate Brachytherapy	2015	57
Increased Ratio of Tumor Necrosis Factor–α to Interleukin‐10 Production Is Associated with<i>Schistosoma haematobium</i>–Induced Urinary‐Tract Morbidity Alex Wamachi, Jyoti Mayadev, Peter Mungai, The Journal of Infectious Diseases	2004	53
Implant time and process efficiency for CT-guided high-dose-rate brachytherapy for cervical cancer Jyoti Mayadev, Lihong Qi, Susan Lentz, Brachytherapy Adaptive RadiotherapyProcess EfficiencyCervical CancerRadiation TherapyMedicine	2014	52
Dosimetric and feasibility evaluation of a CBCT‐based daily adaptive radiotherapy protocol for locally advanced cervical cancer Daniela Branco, Jyoti Mayadev, Kevin L. Moore, Journal of Applied Clinical Medical Physics	2022	51
A knowledge-based organ dose prediction tool for brachytherapy treatment planning of patients with cervical cancer Tahir Yusufaly, Karoline Kallis, Aaron B. Simon, Brachytherapy Adaptive RadiotherapyCervical CancerMedicineBrachytherapyTreatment Planning	2020	46

Page 1